Eli Lilly and Company reports $22.97 billion revenue for quarter ended June 30, 2026, up 47.7%
Eli Lilly and Company reported revenue of $22.97 billion for the quarter ended June 30, 2026, an increase of 47.7% from the same quarter a year earlier ($15.56 billion).
For the same period it posted net income of $7.09 billion, up 25.3%, or $7.94 per diluted share (6.29 a year earlier).
That is a net margin of 30.9%.
On Sanad's AAOIFI Standard 21 screen, Eli Lilly and Company is currently compliant: interest-bearing debt is 3.7% of market capitalisation (limit 30%), and impure income is 0.2% of revenue (limit 5%).
Is Eli Lilly and Company halal?
See the full AAOIFI screening of Eli Lilly and Company
See the full AAOIFI screening of Eli Lilly and Company
Source: 10-Q filed with the U.S. Securities and Exchange Commission on August 5, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.